Intelligence · Clinical Development
Pipeline search results
Programs matching “alcohol” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 117 pipeline programs matching "alcohol" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Miricorilant
CORCEPT THERAPEUTICS INC
Nonalcoholic Steatohepatitis (NASH)
3 trials -
Miricorilant (Cohort A)
CORCEPT THERAPEUTICS INC
Nonalcoholic Steatohepatitis (NASH)
1 trial -
NN9500-4656
NovoThirteen
Non-alcoholic steatohepatitis (NASH)
1 trial -
NN9500-7730
NovoThirteen
alcohol-related liver disease
1 trial -
Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Dependence
1 trial -
Naltrexone
BRIGHT MINDS BIOSCIENCES INC.
Alcohol-Related Disorders
3 trials -
Namodenoson
Can-Fite BioPharma
NASH - Nonalcoholic Steatohepatitis
1 trial -
Namodenoson, Matching placebo for namodenoson
Can-Fite BioPharma
Non-Alcoholic Steatohepatitis (NASH) with F1-3 fibrosis
1 trial -
ORMD-0801 QD
ORAMED PHARMACEUTICALS INC.
Nonalcoholic Steatohepatitis (NASH)
1 trial -
Oral Insulin
ORAMED PHARMACEUTICALS INC.
Non-Alcoholic Steatohepatitis (NASH)
1 trial -
Oxytocin
United Therapeutics Europe Ltd
Alcohol Use Disorder
1 trial -
PF-05190457
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
Placebo
Lacuna Pharma Pty Ltd
Severe Alcohol-Associated Hepatitis
1 trial -
Rencofilstat
Hepion Pharmaceuticals
Nonalcoholic Steatohepatitis (NASH)
1 trial -
SHP626
Mirum Pharmaceuticals International B.V.
Non-Alcoholic Steatohepatitis
3 trials -
Sertraline
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
TEV-45478
Teva Pharma GmbH
Nonalcoholic Steatohepatitis
1 trial -
TVB-2640
Sagimet Biosciences
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
1 trial -
VK2809
Viking Therapeutics
NASH - Nonalcoholic Steatohepatitis
1 trial -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Alcohol Dependence
1 trial -
Vitamin E
NORTHWEST BIOTHERAPEUTICS INC
Nonalcoholic Fatty Liver Disease
1 trial -
Zonisamide
United Therapeutics Europe Ltd
Alcohol Dependence
1 trial -
varenicline
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
A study to compare two different aramchol formulations in healthy volunteers.
Galmed Pharmaceuticals
Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.